Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study

General Info

Geography

United States of America (USA)

Coverage type

Country

Time period covered

January, 2006 - December, 2010

Data type

Scientific literature

Keywords

Blood disorders, Hemoglobin, Hemolytic anemias, Ischemic stroke, Sickle cell disorders, Stroke

Citation

Authors

Nouraie, M, Darbari, D S, Rana, S, Minniti, C P, Castro, O L, Luchtman-Jones, L, Sable, C, Dham, N, Kato, G J, Gladwin, M T, Ensing, G, Arteta, M, Campbell, A, Taylor, J G, Nekhai, S, Gordeuk, V R

Journal

Am J Hematol

Pages

766-774

Publication year

2020

Suggested citation

Nouraie, M, Darbari, D S, Rana, S, Minniti, C P, Castro, O L, Luchtman-Jones, L, Sable, C, Dham, N, Kato, G J, Gladwin, M T, Ensing, G, Arteta, M, Campbell, A, Taylor, J G, Nekhai, S, Gordeuk, V R. Tricuspid regurgitation velocity and other biomarkers of mortality in children, adolescents and young adults with sickle cell disease in the United States: The PUSH study. Am J Hematol. 2020; 95(7): 766-774.